WallStreetZenWallStreetZen

NASDAQ: CRON
Cronos Group Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for CRON

Based on 1 analyst offering 12 month price targets for Cronos Group Inc.
Min Forecast
$2.50+3.73%
Avg Forecast
$2.50+3.73%
Max Forecast
$2.50+3.73%

Should I buy or sell CRON stock?

Based on 1 analyst offering ratings for Cronos Group Inc.
Sell
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
1 analysts 100%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CRON stock forecasts and price targets.

CRON stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-08

1 of 1

Forecast return on equity

Is CRON forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.66%

Forecast return on assets

Is CRON forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

CRON revenue forecast

What is CRON's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$102.6M+17.61%
Avg 2 year Forecast
$141.7M+62.42%
Avg 3 year Forecast
$158.5M+81.68%
CRON's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CRON revenue growth forecast

How is CRON forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
23.05%
Industry
9.04%
Market
10.23%
CRON's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CRON's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CRON vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
CRON$2.41$2.50+3.73%Sell
COLL$34.77$38.60+11.02%Strong Buy
CGC$7.83N/AN/A
DCPH$14.23$23.00+61.63%Strong Buy
EOLS$11.56$22.60+95.50%Strong Buy
View Top Pharmaceutical Stocks

Cronos Group Stock Forecast FAQ

Is Cronos Group Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: CRON) stock is to Sell CRON stock.

Out of 1 analyst, 0 (0%) are recommending CRON as a Strong Buy, 0 (0%) are recommending CRON as a Buy, 0 (0%) are recommending CRON as a Hold, 1 (100%) are recommending CRON as a Sell, and 0 (0%) are recommending CRON as a Strong Sell.

If you're new to stock investing, here's how to buy Cronos Group stock.

What is CRON's revenue growth forecast for 2024-2026?

(NASDAQ: CRON) Cronos Group's forecast annual revenue growth rate of 23.05% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 9.04%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.23%.

Cronos Group's revenue in 2024 is $87,241,000.On average, 2 Wall Street analysts forecast CRON's revenue for 2024 to be $39,121,262,318, with the lowest CRON revenue forecast at $38,206,145,071, and the highest CRON revenue forecast at $40,036,379,565. On average, 1 Wall Street analysts forecast CRON's revenue for 2025 to be $54,030,047,470, with the lowest CRON revenue forecast at $54,030,047,470, and the highest CRON revenue forecast at $54,030,047,470.

In 2026, CRON is forecast to generate $60,435,868,201 in revenue, with the lowest revenue forecast at $60,435,868,201 and the highest revenue forecast at $60,435,868,201.

What is CRON's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: CRON) forecast ROA is N/A, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of N/A.

What is CRON's Price Target?

According to 1 Wall Street analyst that have issued a 1 year CRON price target, the average CRON price target is $2.50, with the highest CRON stock price forecast at $2.50 and the lowest CRON stock price forecast at $2.50.

The Wall Street analyst predicted that Cronos Group's share price could reach $2.50 by Apr 8, 2025. The average Cronos Group stock price prediction forecasts a potential upside of 3.73% from the current CRON share price of $2.41.

What is CRON's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: CRON) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.